HIV and hepatitis C co-infection.
Infections with HIV and hepatitis C (HCV) are individually severe diseases that call for complex medical managements. HIV-HCV co-infection complicates the medical management of both diseases. This paper provides an overview of HIV-HCV co-infection with a brief review of the natural history of hepatitis C as it applies to the co-infected patient and recommendations for the diagnosis and medical management of the co-infected patient.
Dwyer
James T
JT
UMDNJ-School of Osteopathic Medicine/Garden State Infectious Disease Associates, Stratford, USA.
Paul
Sindy M
SM
D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects; D015897:Comorbidity; D000075202:Contraindications; D004338:Drug Combinations; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects
D000998:Antiviral Agents; D004338:Drug Combinations; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b; C100416:peginterferon alfa-2a